Mardil Medical: Ventricular Reshaping To Treat Functional Mitral Regurgitation
Mardil Medical Inc.’s VenTouch System for treating functional mitral valve regurgitation is intended to reshape and correct the geometry of the dilated heart, reduce or eliminate mitral valve regurgitation, and reduce heart wall stressors, all leading to a beneficial reverse remodeling effect.
You may also be interested in...
No device-related warning letters were released by the US FDA the week of 19 January.
Following a €2.5m award from the European Commission’s EIC Accelerator Program, Paris based CorWave has become the first EU company to obtain EIC fund investment. The company is developing a new pulsatile LVAD.
The UK biotech is set for a NASDAQ launch which could propel it to its first commercial launch by 2022.